Sarepta Therapeutics, Inc. SRPT Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s equity method investments?
- Sarepta Therapeutics, Inc. (SRPT) reported equity method investments of $81.94M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s equity method investments changed year-over-year?
- Sarepta Therapeutics, Inc.'s equity method investments decreased by 24.9% year-over-year, from $109.13M to $81.94M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.